恆指午後重現沽壓跌破24,900 阿里/藥明生物/平安回吐逾4%-5%
高盛調低美國今明兩年經濟增長預測,紐約期油昨晚續升曾突破82美元創近七年高,觸發市場對高通脹可能持續憂慮,加上企業踏入季績期投資者入市態度審慎。美股三大指數反覆兩連跌後,期貨全面續跌0.5%,道指期貨報34,209,跌167點。亞太區主要股市下跌,日經回吐0.9%,韓股及台股續跌逾1%,滬指及深成午後跌幅擴至1.8%及2.2%,分別報3,526及14,054。
恆指繼昨天向上受制50天線收窄升幅後,今早扭三連漲(累升1,358點),低開329點或1.3%報24,995,考驗24,900獲承接,早段跌幅曾收窄至不足140點,惟午後跟隨A股跌破今早低位,低見24,865,現報24,880,急吐444點或1.7%,成交額1,039億元。
藍籌股普遍向下,尤其是藥明生物(02269.HK)及中國平安(02318.HK)回吐逾半成,報106.3元及56.8元,後者結束四連升。舜宇(02382.HK)扭三連升重失10天線(199.45元),最低見184.2元,現報192.3元,回吐4.6%。友邦(01299.HK)跌1.5%報87.3元,股價三連跌。
過去三天的升市火車頭三大新經濟股美團(03690.HK)、騰訊(00700.HK)及阿里巴巴(09988.HK)依次回吐1.7%-4.3%,分別低見269.4元、480.2元及159元。小米(01810.HK)跌3%報21元,股價失守10天線(21.2元)。比亞迪(01211.HK)回吐2.4%報252.6元,重失50天線(257.5元)。此外,逆價走低的中海油(00883.HK)及中石油(00857.HK)回吐3.1%及2.7%,分別報8.62元及4元。
不過,四大藍籌內房逆市向好,尤其是潤地(01109.HK)及碧桂園(02007.HK)扭兩連跌,股價回升逾2%報31.95元及7.67元。此外,內需股以李寧(02331.HK)及申洲(02313.HK)表現最好,股價升近2%,分別高見82.6元及161.3元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.